West End Advisors, LLC Abbott Laboratories Transaction History
West End Advisors, LLC
- $3.92 Billion
- Q4 2024
A detailed history of West End Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, West End Advisors, LLC holds 23 shares of ABT stock, worth $2,940. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 20
15.0%
Holding current value
$2,940
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ABT
# of Institutions
3,208Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$21.5 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.81 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.41 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.82 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $224B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...